Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/11/2018
SIETES contiene 92578 citas

 
 
 1 a 20 de 1444 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Cohen LS, Góez-Mogollón L, Sosinsky AZ, Savella GM, Viguera AC, Chitayat D, Hernández-Díaz S, Freeman MP. Risk of major malformations in infants following first-trimester exposure to quetiapine. Am J Psychiatry 2018:16 de agosto. [Ref.ID 102798]
2. Cita con resumen
Anónimo. Gadolinium, IRM et grossesse: des risques pour l'enfant à naître. Prescrire 2018;38:513-5. [Ref.ID 102762]
3. Cita con resumen
Viktorin A, Levine SZ, Altemus M, Reichenberg A, Sandin S. Paternal use of antidepressants and offspring outcomes in Sweden: nationwide prospective cohort study. BMJ 2018;361:k2233. [Ref.ID 102749]
4.Tiene citas relacionadas Cita con resumen
Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolutegravir treatment from the time of conception. N Engl J Med 2018:24 de julio. [Ref.ID 102748]
5.Tiene citas relacionadas Cita con resumen
Rasmussen SA, Barfield W, Honein MA. Protecting mothers and babies — A delicate balancing act. N Engl J Med 2018:24 de julio. [Ref.ID 102747]
6. Cita con resumen
Anónimo. Valproato (Depakine / Depakine Crono): programa de prevención de embarazos. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2018:24 de julio. [Ref.ID 102721]
7. Cita con resumen
Given JE, Loane M, Garne E, Addor M-C, Bakker M, Bertaut-Nativel B, Gatt M, Klungsoyr K, Lelong N, Morgan M, Neville AJ, Pierini A, Rißmann A, Dolk H. Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study. BMJ 2018;361:k2477. [Ref.ID 102696]
8.Enlace a cita originalTiene citas relacionadas
Kerr MP. Guidance is needed on valproate in pregnancy for those without capacity. BMJ 2018;361:29 de mayo. [Ref.ID 102684]
9.Enlace a cita originalTiene citas relacionadas Cita con resumen
Braillon A, Bewley S. Prescribing in pregnancy shows the weaknesses in pharmacovigilance. BMJ 2018;361:29 de mayo. [Ref.ID 102683]
10.Enlace a cita originalTiene citas relacionadas Cita con resumen
Angus-Leppan H, Liu RSN. Weighing the risks of valproate in women who could become pregnant. BMJ 2018;361:18 de abril. [Ref.ID 102682]
11.Enlace a cita original Cita con resumen
Kioumourtzoglou M-A, Coull BA, O’Reilly EJ, Ascherio A, Weisskopf MG. Association of exposure to diethylstilbestrol during pregnancy with multigenerational neurodevelopmental deficits. JAMA Pediatrics 2018;172:670-7. [Ref.ID 102638]
12.Enlace a cita original Cita con resumen
13. Cita con resumen
Hirschler B. Regulators flag possible birth defect link to GSK's HIV drug. Reuters Health News 2018:18 de mayo. [Ref.ID 102606]
15.Enlace a cita original Cita con resumen
Bergman JEH, Lutke LR, Gans ROB, Addor M-C, Barisic I, Clavero-Carbonell C, Garne E, Gatt M, Klungsoyr K, Lelong N, Lynch C, Mokoroa O, Nelen V, Neville AJ, Pierini A, Randrianaivo H, Rißmann A, Tucker D, Wiesel A, Dolk H, Loane M, Bakker MK. Beta-blocker use in pregnancy and risk of specific congenital anomalies: A European case-malformed control study. Drug Saf 2018;41:415-27. [Ref.ID 102566]
16.Enlace a cita original Cita con resumen
Seo GH, Kim TH, Chung JH. Antithyroid drugs and congenital malformations: a nationwide Korean cohort study. Ann Intern Med 2018;168:20 de marzo. [Ref.ID 102564]
17.Enlace a cita original Cita con resumen
Charlton RA, Bettoli V, Bos HJ, Engeland A, Garne E, Gini R, Hansen AV, de Jong-van den Berg LTW, Jordan S, Klungsøyr K, Neville AJ, Pierini A, Puccini A, Sinclair M, Dolk DTH. The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures. Eur J Clin Pharmacol 2018;74:abril. [Ref.ID 102561]
18. Cita con resumen
Hirschler B. UK bans Sanofi epilepsy drug without pregnancy prevention plan. Reuters Health News 2018:24 de abril. [Ref.ID 102553]
19. Cita con resumen
Pennel PB. Prescribing antiepileptic drugs to women of reproductive age. Lancet Neurol 2018;17:485-6. [Ref.ID 102517]
20. Cita con resumen
Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F, for the EURAP study group. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol 2018;17:530-8. [Ref.ID 102516]
Seleccionar todas
 
 1 a 20 de 1444 siguiente >>